Executive Editor
Hee-Jeong Im, Sampen Ph.D
Professor, Departments of Biochemistry, Orthopaedic Surgery and Internal Medicine (section of Rheumatology), Rush University Medical Center, USA · United States
Editorial leadership for Journal of New Developments in Chemistry ISSN 2377-2549
Research interests
- Musculoskeletal Diseases
- Arthritis
- Orthopaedic Research
Biography
- Dr. Im-Sampen’s long-term dedicated research on musculoskeletal diseases has been recognized by “Arthritis National Research Foundation Scholar Award”.
- “Kappa Delta Elizabeth Winston Lanier Award” from the Orthopaedic Research Society (ORS) where she serves as an Executive Member of the Women’s Leadership. .
- Her successful mentorship has been recognized by one of her ex-graduate students (Dongyao Yan, PhD) who received John E.
- Turfant Ed.D Award for Excellence in Graduate College Research as well as recent funding by one of her postdoctoral fellows (Xin Li, MD, PhD) to investigate the pathological role of microRNA in OA from Arthritis National Research Foundation.
Membership:
- 2012-present - Sigma Xi Executive Member
- 2006-present - Member of the Society for Physical Regulation in Biology and Medicine (SPRBM)
- 2004-present - Member of the American Society for Bone and Mineral Research (ASBMR)
- 2000-present -Member of the Orthopedic Research Society (ORS)
- 2000-present - Member of American Association for the Advancement of Science (AAAS)
- 2000-present - Member of Mayo Fellow&rsquos Association
- 2000-present - Toastmasters International Speakers Forum in Chicago (Vice President)
- 1997-present - Member of Genetic Engineering
- 1997-present - Member of Biotechniques
- 1997-present - Member of The Scientist
- 1997-present - Member of American Biotechnology Laboratory
Considering JNDC for your work?
This journal is guided by Hee-Jeong Im, Sampen (Professor, Departments of Biochemistry, Orthopaedic Surgery and Internal Medicine (section of Rheumatology), Rush University Medical Center, USA) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.